Biomerica, Inc.
BMRA
$2.80
$0.041.45%
NASDAQ
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -33.07% | -31.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -33.07% | -31.60% | |||
| Cost of Revenue | -9.73% | -8.26% | |||
| Gross Profit | -1,384.21% | -95.65% | |||
| SG&A Expenses | 5.53% | -13.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.69% | -11.41% | |||
| Operating Income | -29.26% | -21.85% | |||
| Income Before Tax | -31.88% | -22.46% | |||
| Income Tax Expenses | 225.00% | -33.33% | |||
| Earnings from Continuing Operations | -32.76% | -22.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.76% | -22.42% | |||
| EBIT | -29.26% | -21.85% | |||
| EBITDA | -29.60% | -22.45% | |||
| EPS Basic | -44.28% | -9.24% | |||
| Normalized Basic EPS | -43.34% | -9.27% | |||
| EPS Diluted | -50.51% | -1.02% | |||
| Normalized Diluted EPS | -43.34% | -9.27% | |||
| Average Basic Shares Outstanding | -7.98% | 12.06% | |||
| Average Diluted Shares Outstanding | -7.98% | 12.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||